Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CIP2A confirms its prognostic value in triple-negative breast cancer.
Cristóbal I, Zazo S, Torrejón B, Pedregal M, Madoz-Gúrpide J, Lluch A, Eroles P, Rovira A, Albanell J, García-Foncillas J, Rojo F. Cristóbal I, et al. Among authors: torrejon b. Oncogene. 2017 Jun 8;36(23):3357-3358. doi: 10.1038/onc.2016.474. Epub 2017 Jan 9. Oncogene. 2017. PMID: 28068327 No abstract available.
Deregulation of miR-92a in locally advanced rectal cancer.
Cristóbal I, Torrejón B, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Cristóbal I, et al. Among authors: torrejon b. Genes Chromosomes Cancer. 2016 Jul;55(7):612. doi: 10.1002/gcc.22357. Epub 2016 May 2. Genes Chromosomes Cancer. 2016. PMID: 27015298 No abstract available.
Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.
Cristóbal I, Caramés C, Rincón R, Manso R, Madoz-Gúrpide J, Torrejón B, González-Alonso P, Rojo F, García-Foncillas J. Cristóbal I, et al. Among authors: torrejon b. Oncotarget. 2017 Jun 20;8(25):40169-40180. doi: 10.18632/oncotarget.11174. Oncotarget. 2017. PMID: 27517624 Free PMC article.
Targeting PP2A to overcome enzalutamide resistance in AR+ breast tumors.
Cristóbal I, Torrejón B, Pedregal M, Rojo F, García-Foncillas J. Cristóbal I, et al. Among authors: torrejon b. Endocr Relat Cancer. 2017 Jan;24(1):L5-L6. doi: 10.1530/ERC-16-0444. Epub 2016 Oct 20. Endocr Relat Cancer. 2017. PMID: 27765801 No abstract available.
25 results